1/13
08:56 pm
olma
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
Medium
Report
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
1/9
11:46 am
olma
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
Medium
Report
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
1/9
06:10 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/8
09:47 pm
olma
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors [Yahoo! Finance]
Medium
Report
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors [Yahoo! Finance]
1/7
10:11 am
olma
The banker, the brothers, the friends and their frauds [Investment Executive - News]
Medium
Report
The banker, the brothers, the friends and their frauds [Investment Executive - News]
1/7
08:02 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/7
02:01 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/5
04:30 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/5
07:00 am
olma
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
12/12
08:06 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Citigroup Inc. from $21.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Citigroup Inc. from $21.00 to $60.00. They now have a "buy" rating on the stock.
12/11
01:19 pm
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $45.00 to $48.00. They now have an "outperform" rating on the stock.
Low
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $45.00 to $48.00. They now have an "outperform" rating on the stock.
12/11
12:31 pm
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $26.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $26.00 to $38.00. They now have a "buy" rating on the stock.
12/11
10:38 am
olma
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT [Yahoo! Finance]
Medium
Report
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT [Yahoo! Finance]
12/11
08:07 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at HC Wainwright from $36.00 to $45.00. They now have a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at HC Wainwright from $36.00 to $45.00. They now have a "buy" rating on the stock.
12/10
09:08 am
olma
Roche boosts Olema after additional late-stage trial data for breast cancer drug [Seeking Alpha]
Medium
Report
Roche boosts Olema after additional late-stage trial data for breast cancer drug [Seeking Alpha]
12/2
04:30 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/21
06:11 pm
olma
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Medium
Report
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/21
04:30 pm
olma
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
Medium
Report
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
11/21
01:20 pm
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $26.00. They now have a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $26.00. They now have a "buy" rating on the stock.
11/20
04:11 pm
olma
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
Medium
Report
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
11/20
04:01 pm
olma
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Medium
Report
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/19
11:43 am
olma
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution [Seeking Alpha]
High
Report
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution [Seeking Alpha]
11/19
07:00 am
olma
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
Medium
Report
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
11/19
06:37 am
olma
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche's Breast Cancer Trial Success [Yahoo! Finance]
Medium
Report
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche's Breast Cancer Trial Success [Yahoo! Finance]
11/18
04:55 pm
olma
Olema Pharmaceuticals plans public offering of stock, pre-funded warrants; shares down [Seeking Alpha]
Medium
Report
Olema Pharmaceuticals plans public offering of stock, pre-funded warrants; shares down [Seeking Alpha]